Lindsay Short
Family · Rochester, NYNPI 1508029828
Payments from drug & device makers
Across 240 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$881
- Astellas Pharma US Inc$874
- Pfizer$421
- Procept Biorobotics Corporation$419
- AbbVie$409
- Merck$344
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,14594%
- Education$3496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 43 | $881 |
| Astellas Pharma US Inc | 39 | $874 |
| Pfizer | 24 | $421 |
| Procept Biorobotics Corporation | 3 | $419 |
| AbbVie(2 entities) | 18 | $409 |
| Merck | 15 | $344 |
| Johnson & Johnson | 7 | $171 |
| Medtronic | 6 | $170 |
| Olympus America Inc. | 3 | $160 |
| Urovant Sciences Inc | 12 | $151 |
| Accord Healthcare, Inc. | 7 | $141 |
| Antares Pharma, Inc. | 5 | $132 |
| Tolmar, Inc. | 5 | $111 |
| Sanofi | 2 | $100 |
| AstraZeneca | 4 | $82 |
| GSK | 5 | $79 |
| Urogen Pharma, Inc. | 3 | $70 |
| Ferring Pharmaceuticals Inc. | 3 | $69 |
| Blue Earth Diagnostics | 3 | $62 |
| Axonics, Inc. | 2 | $55 |
| Kaleo, Inc. | 3 | $51 |
| Novartis | 2 | $48 |
| Telix Pharmaceuticals | 3 | $48 |
| Bayer | 2 | $42 |
| Coloplast | 2 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $35 |
| Boston Scientific | 2 | $35 |
| Civco Medical Instruments | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Dentsply IH AB | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| Dentsply IH Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Endo USA, Inc. | 1 | $14 |
| USWM, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$250
- AQUABEAM SYSTEM$170
- iTIND System$120
- GEMTESA$110
How this compares
$5,494 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 212 | $187,721 |
| MyrbetriqMirabegron | 161 | $114,196 |
| Mirabegron ErMirabegron | 82 | $37,438 |
| BotoxOnabotulinumtoxina | 20 | $20,741 |
| Testosterone | 48 | $17,858 |
| Tamsulosin Hcl | 792 | $13,400 |
| XyostedTestosterone Enanthate | 13 | $11,258 |
| Bcg (Tice Strain)Bcg Live | 17 | $11,046 |
| Trospium Chloride | 186 | $9,603 |
| Testosterone Cypionate | 92 | $5,147 |
| Finasteride | 316 | $4,512 |
| Methenamine Hippurate | 60 | $4,377 |
| Solifenacin Succinate | 125 | $4,296 |
| NitrofurantoinNitrofurantoin Macrocrystal | 71 | $4,287 |
| Trospium Chloride ErTrospium Chloride | 22 | $3,858 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $881 | $187,721212 claims |
| Astellas Pharma US IncMyrbetriq | $874 | $114,196161 claims |
| AbbVieBotox | $409 | $20,74120 claims |
| Antares Pharma, Inc.Xyosted | $132 | $11,25813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in Rochester
- Stephanie BartlettRochester$63K
- Orlando HarrisRochester$30K
- Laron NelsonRochester$28K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.